期刊
NATURE REVIEWS NEUROSCIENCE
卷 17, 期 4, 页码 201-207出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrn.2016.7
关键词
-
资金
- US National Institutes of Health (NIH) [1RF1AG051485-01]
- Cure Alzheimer disease Fund
- Lilly Innovation Fellowship Award (Eli Lilly and Company)
Genome-wide association studies have identified rare variants of the gene that encodes triggering receptor expressed on myeloid cells 2 (TREM2)-an immune receptor that is found in brain microglia-as risk factors for non-familial Alzheimer disease (AD). Furthermore, animal studies have indicated that microglia have an important role in the brain response to amyloid-beta(A beta) plaques and that TREM2 variants may have an impact on such a function. We discuss how TREM2 may control the microglial response to A beta and its impact on microglial senescence, as well as the interaction of TREM2 with other molecules that are encoded by gene variants associated with AD and the hypothetical consequences of the cleavage of TREM2 from the cell surface.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据